Hello AFSPA Members! I am happy to provide an update on the EncircleRx program designed to support members taking GLP-1 drugs for weight management.

We initially launched this program on January 1, 2026. In the first few weeks of the year, it became clear that several back-end issues were preventing the program from functioning properly and, in too many cases, delaying members’ access to their prescriptions. We temporarily suspended the requirement that participation in Teladoc Health programs be a prerequisite for obtaining prescriptions.

I have been in daily contact with both Evernorth/Express Scripts and Teladoc Health regarding the issues that led to the suspension and the work to address them. We have made immense progress in recent weeks. After implementing numerous fixes and weeks of monitoring, we are ready to turn back on the Teladoc Health requirements effective March 1, 2026.

Here is what that means for members with prescription coverage under the High Option benefits and obtaining GLP-1s for weight management – that is, Wegovy or Zepbound – from pharmacies in the U.S.:

• If you haven’t already done so, please enroll in either the Teladoc Advanced Weight Management Program or the Teladoc Advanced Pre-Diabetes Program through the Teladoc Health App. You must be enrolled prior to your fill of a GLP-1 for weight management in 2026.
• Use the program. Make sure you weigh in on the Teladoc-provided scale at least 4 times per month and engage with the program’s support features in the app at least 4 times per month. There are multiple ways to do this: track your activity, log your food, set goals, read articles, work one-on-one with a coach, and more. Ongoing participation through weigh-ins and app engagements is required for ongoing coverage of refills throughout the year.
• Work with your provider to ensure your prior authorization is complete. All prior authorizations for GLP-1s for weight management had to be updated, effective January 1, 2026, to ensure members meet the new program’s requirements. Providers can initiate the prior authorization through the EviCore online portal or by calling 800-417-1764. Members cannot do this; prior authorizations must be completed by your prescriber, and often, they must upload or fax documentation to complete the prior authorization.

I sincerely apologize to members who were impacted by the issues with this program. I am confident that we are ready to move forward with it, effective March 1, 2026.

Thank you,

Kyle Longton, CEO